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ABSTRACT
Purpose: We aimed to estimate the prevalence of trachoma in each district (“woreda”) of Tigray
Region, Ethiopia.
Methods: We conducted 11 cross-sectional community-based surveys in evaluation units covering
34 rural woredas from January to March 2013 using the standardized methodology developed for
the Global Trachoma Mapping Project.
Results: Teams visited 8034 households in 275 villages. A total of 28,581 consenting individuals were
examined, 16,163 (56.7%) of whom were female. The region-wide adjusted trichiasis prevalence was
1.7% in those aged 15 years and older. All evaluation units mapped had a trichiasis prevalence over
the World Health Organization elimination threshold of 0.2% in people aged 15 years and older. The
region-wide adjusted prevalence of the clinical sign trachomatous inflammation – follicular (TF) in
children aged 1–9 years was 26.1%. A total 10 evaluation units, covering 31 woredas, with a combined
rural population of 4.3 million inhabitants, had a prevalence of TF ≥10%, and require full implementa-
tion of the SAFE strategy (surgery, antibiotics, facial cleanliness, and environmental improvement) for
at least 3 years before impact surveys are undertaken. Of these, four evaluation units, covering 12
woredas, with a combined rural population of 1.7 million inhabitants, had a TF prevalence ≥30%.
Conclusion: Both active trachoma and trichiasis are public health problems in Tigray, which needs
urgent implementation of the full SAFE strategy.
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Introduction
Trachoma is a chronic infectious keratoconjunctivitis that
is a major cause of blindness inmany developing countries.
It presents initially as a follicular conjunctivitis, sometimes
with superficial keratitis and corneal vascularization, and
gradually progresses (in some people, with repeated ocular
Chlamydia trachomatis infection) to conjunctival scarring
and lid distortion. Damage to the cornea occurs from the
chronic inflammatory disease and later (and more impor-
tantly) from exposure and trauma from distorted lids and
in-turned lashes. Endemic trachoma is a major cause of
blindness in poorer rural communities of developing coun-
tries, especially in arid areas.1,2
Ethiopia is one of the world’s most trachoma-endemic
countries, with trachoma a major preventable cause of
blindness nationwide. Tigray is the northern-most region
in Ethiopia, and has an estimated population of 4,316,988,
of which 80.5% live in rural areas.3 A national survey
carried out in 2005–2006 found an estimated national
prevalence of active trachoma (trachomatous inflamma-
tion – follicular, TF, and/or trachomatous inflammation –
intense, TI) of 40.1% in children aged 1–9 years, with an
estimated TF prevalence of 25.6% in children in Tigray.4,5
The World Health Organization (WHO) and partners
have targeted trachoma for elimination as a public health
problem by 2020, by implementation of the SAFE strategy
(surgery for in-turned eyelashes, antibiotics to clear infec-
tion, and facial cleanliness and environmental improve-
ment to reduce infection transmission).6,7 Knowing the
baseline prevalences of TF and trichiasis is crucial for
control programs, to help guide planning on where and
for how long SAFE interventions are required.
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We carried out cross-sectional population-based
prevalence surveys to estimate the prevalence of TF
among children aged 1–9 years, and the prevalence of
trichiasis among adults aged 15 years and older, in 11
evaluation units (EUs) covering 34 districts (woredas)
throughout Tigray Region.3
Materials and methods
Survey methodology
Tigray Region is divided into seven zones (Central, Eastern,
South Eastern, South, West, Northwest and Mekele). All
rural zones were included in the survey. Urban areas,
including Mekele Special Zone and all woreda towns,
were not surveyed. Surveys were undertaken using the
standardized Global Trachoma Mapping Project (GTMP)
sampling methodology.8 The WHO definition of a “dis-
trict” for the purposes of trachoma prevalence estimates is
an administrative area with a population of 100,000–
250,000 people. In Tigray, trachoma was expected to be
highly endemic, and so larger populations were included in
each survey by grouping woredas into EUs of populations
up to 500,000 people, so that interventions can be provided
in a timely manner, where needed (Figure 1).
We used a 2-stage, cluster random sampling metho-
dology, with clusters (kebeles) selected using a probability
proportional to size sampling technique. The kebele was
the primary sampling unit, with each kebele regarded as a
cluster. Using the latest available census data,3 it was
estimated that if teams could survey 30 households per
day, then the required sample size of children aged 1–9
years would be reached if 26 kebeles were surveyed for
each EU. The list of all kebeles in each EU was obtained
from the regional government. Kebeles were excluded if
they were considered insecure or not accessible within 90
minutes’ walk from the furthest point that could be
reached in a 4-wheel drive vehicle. A developmental
team (DT) is the smallest administrative unit in each
zone, and served as our secondary sampling unit, with
each DT comprising approximately 25–30 households.
On the day of the survey, at the kebele, a DT was
Figure 1. Adjusted prevalence of trachomatous inflammation – follicular (TF) in children aged 1–9 years by evaluation unit, Global
Trachoma Mapping Project, Tigray Region, Ethiopia, 2013.
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randomly selected by drawing lots. All households in the
selected DT were included in the survey, with all house-
hold members at least 1 year of age eligible for inclusion.
Informed verbal consent was obtained before assess-
ment. Clinical assessments were carried out using the
WHO simplified trachoma grading system5 and a 2.5×
loupe under direct sunlight or torchlight, with the results
called to the recorder. Alcohol hand-gel was used between
individuals to minimize carry-over contamination.
Data collection
Data were collected using a bespoke Android smart-
phone application.8 Both recorders and trachoma gra-
ders were required to attend the 5-day (version 1) GTMP
training course, and pass an exit exam. Full details of the
training and examination process are outlined
elsewhere.8 Nine teams, each made up of a trachoma
grader, a data recorder, and a driver, were used. A super-
visor (ST) was in charge of overseeing the work of
graders and recorders and assisting them technically, as
well as coordinating and leading the overall survey.
Ethical considerations
Ethics approval was obtained from the Tigray Regional
Health Bureau Ethics Committee (2136/7767/05). The
overall GTMP survey methodology was approved by the
London School of Hygiene & Tropical Medicine Ethics
Committee (6319). Informed verbal consent was
obtained from all adult individuals who participated in
the survey. For children aged <15 years, parents or adult
guardians provided consent. All participants found to
have active trachoma were provided with 1% tetracycline
eye ointment for 6 weeks and those with trichiasis were
referred (using a standard referral form) to a nearby
health facility for consideration of corrective surgery.
Data analysis
All data analysis was carried out in R 3.0.2 (2013, R
Foundation for Statistical Computing, Vienna, Austria),
using the GTMP analysis approaches described elsewhere.8
Sample outcomes proportions were adjusted at cluster level
to estimates population-level prevalences, with the overall
EU prevalence the mean of all adjusted cluster-level pro-
portions in a given EU. TF prevalence estimates were
adjusted in 1-year age bands, and trichiasis estimates
were adjusted for sex and age in 5-year age bands, using
the 2007 Tigray census data.3 Confidence intervals (CIs)
were constructed by bootstrapping the adjusted cluster-
level outcomes proportions, and taking the 2.5th and
97.5th centiles from the list of 10,000 bootstrap iterates.
Results
Surveys were carried out from January 28 to March 30,
2013. A total of 32,815 people were enumerated from 11
EUs covering 34 woredas, with 8034 households visited in
275 kebeles. Overall, 28,581 people (87.1%) consented to
examination and 16,163 (56.7%) of those examined were
female. Overall, 10,296 children aged 1–9 years were
enumerated, with 10,023 (97.4%) examined. There was a
mean of 1.25 children aged 1-9 years per household.
Adjusted TF prevalences ranged from 9.3% (95% CI
6.0–11.3%) in the EU covering Kafta Humera, Welkait
and Tsegede woredas, to 41.4% (95% CI 33.8–51.2%) in
the EU covering Wefla and Alamata woredas (Table 1,
Figure 1).
Adjusted trichiasis prevalences in those aged 15
years and older ranged from 0.6% (95% CI 0.1–1.1%)
in the EU covering Kafta Humera, Welkait and Tsegede
woredas, to 2.6% (95% CI 1.8–3.1%) in the EU covering
Degua Temben, Saharti Samre, Hintalo Wejirat and
Enderta woredas (Table 2, Figure 2).
Table 1. Prevalence of trachomatous inflammation – follicular (TF) in children aged 1–9 years by evaluation unit, Global Trachoma
Mapping Project, Tigray Region, Ethiopia, 2013.
Evaluation unit Examined, n TF cases, n Unadjusted TF, % Adjusteda TF, % (95% CIb)
Laelay Maychew, Naeder Adet, Tahtay Maychew 766 266 34.7 32.6 (27.0–38.9)
Adwa, Mereb Leke, Entecho 792 212 26.8 23.7 (16.6–29.7)
Kolla Tembiyen, Werei Leke, Tanqua Abergele 857 249 29.1 29.5 (22.3–34.6)
Degua Temben, Saharti Samre, Hintalo Wejirat, Enderta 936 419 44.7 39.1 (30.0–47.3)
Erob, Ganta Afeshum, Glomekada, Saesie Tsaedaemba 762 163 21.4 22.5 (14.4–28.5)
Hawzen, Wukero, Atsbi Wenberta 973 185 19.0 20.0 (15.8–23.3)
Wefla, Alamata 942 408 43.3 41.4 (33.8–51.2)
Alaje, Endamehoni, Raya Azebo 930 373 40.1 41.0 (32.1–50.0)
Kafta Humera, Welkait, Tsegede 1013 100 9.9 9.3 (6.0–11.3)
Asgede Tsimbila, Medebay Zana, Tahtay Koraro, Tselemti 1007 185 18.4 18.3 (13.1–23.9)
Laelay Adiyabo, Tahtay Adiyabo 1045 113 10.8 10.2 (6.3–14.6)
aAdjusted for age in 1-year age bands using the 2007 Ethiopian national census data for Tigray Region.
b95% CIs from the 2.5th and 97.5th centiles of bootstrapped adjusted cluster-level proportions, to account for the clustered sampling design.
CI, confidence interval.
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Discussion
Trachoma is highly endemic in Tigray Region. Overall, 19
woredas require mass drug administration (MDA) with
azithromycin for 3 years before re-survey, and 12 woredas
require MDA for at least 5 years before re-survey, in
addition to the F and E components of the SAFE strategy.
One EU covering three woredas in Western Tigray Zone
(Kafta Humera, Welkait and Tsegede) had a TF preva-
lence in the range 5.0–9.9%. At this prevalence, the WHO
Table 2. Prevalence of trichiasis in those aged 15 years and older by evaluation unit, Global Trachoma Mapping Project, Tigray
Region, Ethiopia, 2013.
Evaluation unit Examined, n Trichiasis cases, n Unadjusted trichiasis, % Adjusteda trichiasis, % (95% CIb)
Laelay Maychew, Naeder Adet, Tahtay Maychew 1237 50 4.0 1.9 (1.1–2.8)
Adwa, Mereb Leke, Entecho 1217 46 3.8 2.3 (1.6–3.0)
Kolla Tembiyen, Werei Leke, Tanqua Abergele 1208 29 2.4 1.4 (0.8–1.8)
Degua Temben, Saharti Samre, Hintalo Wejirat, Enderta 1435 66 4.6 2.6 (1.8–3.3)
Erob, Ganta Afeshum, Glomekada, Saesie Tsaedaemba 1055 25 2.4 0.7 (0.3–1.2)
Hawzen, Wukero, Atsbi Wenberta 1366 46 3.4 2.0 (1.5–2.8)
Wefla, Alamata 1574 61 3.9 2.3 (1.2–3.0)
Alaje, Endamehoni, Raya Azebo 1595 48 3.0 1.9 (1.5–3.0)
Kafta Humera, Welkait, Tsegede 1267 14 1.1 0.6 (0.1–1.1)
Asgede Tsimbila, Medebay Zana, Tahtay Koraro, Tselemti 1550 36 2.3 1.3 (0.8–1.9)
Laelay Adiyabo, Tahtay Adiyabo 1511 35 2.3 1.3 (0.7–1.8)
aAdjusted for sex and age in 5-year age bands using the 2007 Ethiopian national census data for Tigray Region.
b95% CIs from the 2.5th and 97.5th centiles of bootstrapped adjusted cluster-level proportions, to account for the clustered sampling design.
CI, confidence interval.
Figure 2. Adjusted prevalence of trichiasis in those 15 years and older by evaluation unit, Global Trachoma Mapping Project, Tigray
Region, Ethiopia, 2013.
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recommends a single round of azithromycin MDA, plus
implementation of the F and E components of the SAFE
strategy, before re-survey.
We excluded kebeles that were more than 90 min-
utes walk from the furthest point that could be reached
in a 4-wheel drive vehicle. Given that we anticipate
trachoma to be mostly found in rural, isolated, popula-
tions, it is probable that some cluster of disease was
missed by this approach. In our case a balance was
sought between making sampled kebeles as representa-
tive of the rural population as possible, and the prac-
tical considerations that come into any survey carried
out in extreme geographical environments. In order to
ensure a complete geographical covering in implement-
ing future MDAs, kebeles cannot be excluded by this
criteria, and it is possible that with decreasing trachoma
prevalence, more isolated areas will have to be included
in future mapping.
Every EU surveyed had trichiasis prevalence esti-
mates far higher than the WHO trachomatous trichia-
sis elimination threshold of 0.2% of the population
aged 15 years and older. There is an urgent need for
large-scale assessment of rural individuals to case-find
the sizeable number of trichiasis cases who need cor-
rective surgery throughout Tigray. This will require
significant funding to train and deploy case finders
and trichiasis surgeons.
At the time of this survey, WHO had not yet recom-
mended that cases of trichiasis be checked for the pre-
sence of trachomatous conjunctival scarring5 to
confirm the cause of eyelash deviation to be trachoma,
and so the presence or absence of scarring was not
assessed by graders here. As not all cases of trichiasis
are necessarily trachomatous in origin, it is likely that
our trichiasis prevalence estimates will overestimate the
true proportion of trachomatous trichiasis cases in the
population. However, this figure does not consider the
number of cases which will progress from trachoma-
tous scarring to potentially blinding trachomatous
trichiasis9 in the time taken to train and deploy sur-
geons to carry out the current backlog of surgeries. For
this reason, the securing of funding and program plan-
ning should begin as a matter of urgency. The magni-
tude of this task should not be underestimated, and
much effort will be needed to eliminate trachoma as a
public health problem from Tigray Region between
now and the 2020 elimination target.
Declaration of interest
The authors report no conflicts of interest. The authors alone
are responsible for the content and writing of the paper.
Funding
This study was principally funded by the Global Trachoma
Mapping Project (GTMP) grant from the United Kingdom’s
Department for International Development (ARIES: 203145) to
Sightsavers, which led a consortium of non-governmental orga-
nizations and academic institutions to support ministries of
health to complete baseline trachoma mapping worldwide. The
GTMP was also funded by the United States Agency for
International Development (USAID), through the ENVISION
project implemented by RTI International under cooperative
agreement number AID-OAA-A-11-00048, and the END in
Asia project implemented by FHI360 under cooperative agree-
ment number OAA-A-10-00051. A committee established in
March 2012 to examine issues surrounding completion of global
trachoma mapping was initially funded by a grant from Pfizer to
the International Trachoma Initiative. AWS was a Wellcome
Trust Intermediate Clinical Fellow (098521) at the London
School of Hygiene & Tropical Medicine. None of the funders
had any role in project design, in project implementation or
analysis or interpretation of data, in the decisions on where,
how or when to publish in the peer-reviewed press, or in the
preparation of the manuscript.
References
1. Smith JL, Flueckiger RM, Hooper PJ, et al. The geo-
graphical distribution and burden of trachoma in
Africa. PLoS Negl Trop Dis 2013;7. doi:10.1371/jour-
nal.pntd.0002359
2. Burton MJ, Mabey DCW. The global burden of tra-
choma: a review. PLoS Negl Trop Dis 2009;3(10).
doi:10.1371/journal.pntd.0000460
3. Central Statistical Agency of Ethiopia. Population and
Housing Census – Tigray Region, 2007.
4. Berhane Y, Worku A, Bejiga A, et al. Prevalence and
causes of blindness and low vision in Ethiopia. Ethiop J
Health Dev 2008;21:204–210.
5. Thylefors B, Dawson CR, Jones BR, et al. A simple
system for the assessment of trachoma and its compli-
cations. Bull World Health Organ 1987;65:477–483.
6. Bailey R, Lietman T. The SAFE strategy for the elim-
ination of trachoma by 2020: will it work? Bull World
Health Organ 2001;79:233–236.
7. Emerson PM, Burton M, Solomon AW, et al. The
SAFE strategy for trachoma control: using operational
research for policy, planning and implementation. Bull
World Health Organ 2006;84:613–619. http://www.pub
medcentra l .n ih .gov/ar t ic lerender . fcg i?ar t id=
2627433&tool=pmcentrez&rendertype=abstract.
Accessed September 2, 2015.
8. Solomon AW, Pavluck A, Courtright P, et al. The
Global Trachoma Mapping Project: methodology of a
34-country population-based study. Ophthalmic
Epidemiol 2015;22:214–225.
9. Muñoz B, Bobo L, Mkocha H, et al. Incidence of
trichiasis in a cohort of women with and without
scarring. Int J Epidemiol 1999;28:1167–1171. http://
www.ncbi.nlm.nih.gov/pubmed/10661664. Accessed
January 1, 2016.
98 S. T. SHERIEF ET AL.
Appendix
The Global Trachoma Mapping Project Investigators are: Agatha Aboe (1,11), Liknaw Adamu (4), Wondu Alemayehu (4,5),
Menbere Alemu (4), Neal D. E. Alexander (9), Berhanu Bero (4), Simon J. Brooker (1,6), Simon Bush (7,8), Brian K. Chu (2,9),
Paul Courtright (1,3,4,7,11), Michael Dejene (3), Paul M. Emerson (1,6,7), Rebecca M. Flueckiger (2), Allen Foster (1,7),
Solomon Gadisa (4), Katherine Gass (6,9), Teshome Gebre (4), Zelalem Habtamu (4), Danny Haddad (1,6,7,8), Erik Harvey
(1,6,10), Dominic Haslam (8), Khumbo Kalua (5), Amir B. Kello (4,5), Jonathan D. King (6,10,11), Richard Le Mesurier (4,7),
Susan Lewallen (4,11), Thomas M. Lietman (10), Chad MacArthur (6,11), Colin Macleod (3,9), Silvio P. Mariotti (7,11), Anna
Massey (8), Els Mathieu (6,11), Siobhain McCullagh (8), Addis Mekasha (4), Tom Millar (4,8), Caleb Mpyet (3,5), Beatriz
Muñoz (6,9), Jeremiah Ngondi (1,3,6,11), Stephanie Ogden (6), Alex Pavluck (2,4,10), Joseph Pearce (10), Serge Resnikoff (1),
Virginia Sarah (4), Boubacar Sarr (5), Alemayehu Sisay (4), Jennifer L. Smith (11), Anthony W. Solomon
(1,2,3,4,5,6,7,8,9,10,11), Jo Thomson (4); Sheila K. West (1,10,11), Rebecca Willis (2,9).
Key: (1) Advisory Committee, (2) Information Technology, Geographical Information Systems, and Data Processing, (3)
Epidemiological Support, (4) Ethiopia Pilot Team, (5) Master Grader Trainers, (6) Methodologies Working Group, (7)
Prioritisation Working Group, (8) Proposal Development, Finances and Logistics, (9) Statistics and Data Analysis, (10) Tools
Working Group, (11) Training Working Group.
OPHTHALMIC EPIDEMIOLOGY 99
